M

Medisyn Technologies

10 employees

Medisyn Technologies develops pre-qualified proprietary drug compounds for breast, renal, prostate, and lung cancer treatments.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Bioactive compound discovery and Pharmaceutical | Health & Wellness | Animal Health | Agribusiness

Date founded

1999

Funding rounds raised

Total raised

$1.5M

from 1 investors over 1 rounds

M

Medisyn Technologies raised $1.5M on February 17, 2005

Investors: Sherpa Partners

FAQ